Autologous is superior to allogeneic hematopoietic cell transplantation for acute promyelocytic leukemia in second complete remission.
about
Acute promyelocytic leukemia: where did we start, where are we now, and the futureAcute promyelocytic leukemia with cryptic t(15;17) on isochromosome 17: a case report and review of literatureIntravenous busulfan for autologous stem cell transplantation in adult patients with acute myeloid leukemia: a survey of 952 patients on behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.A Canadian consensus on the management of newly diagnosed and relapsed acute promyelocytic leukemia in adultsMatched and mismatched unrelated donor compared to autologous stem cell transplantation for acute myeloid leukemia in first complete remission: a retrospective, propensity score-weighted analysis from the ALWP of the EBMTIndications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015.Autologous stem cell transplantation for adult acute leukemia in 2015: time to rethink? Present status and future prospects.Autologous hematopoietic cell transplantation for acute promyelocytic leukemia in second complete remission: outcomes before and after the introduction of arsenic trioxide.Autologous transplant remains the preferred therapy for relapsed APL in CR2.Arsenic trioxide-based therapy of relapsed acute promyelocytic leukemia: registry results from the European LeukemiaNet.Management of relapsed and refractory childhood acute promyelocytic leukaemia: recommendations from an international expert panel.
P2860
Q26830385-C6037BD7-5F0F-4AF0-B103-44A2D41B73B9Q28073281-9C233FF1-85C4-4E96-A72B-28C26EE08D0DQ33978951-9657CE37-49B5-4047-878E-E4B39DDCB917Q34305899-44329905-E4C2-447F-9EA6-1B4627C89B22Q36121885-D5434C81-B006-4FDA-B2D9-F16DD68E2A1AQ38387292-2DB837F4-DD95-45DD-BA3D-3BD186F6CD3CQ38568355-7965789E-0BFA-4214-A849-E706E48BBFD3Q39323997-8DBBFE30-3FF0-4317-8E83-097C843609F0Q39843411-52ACAED9-A1EC-41DD-959E-CB6EDE6845A0Q41517525-8F4B2607-A8E9-4655-992A-0517121B5FE1Q48791883-A2EC2C0F-D13E-41C9-8805-FEF00E6D40A7
P2860
Autologous is superior to allogeneic hematopoietic cell transplantation for acute promyelocytic leukemia in second complete remission.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Autologous is superior to allo ...... in second complete remission.
@ast
Autologous is superior to allo ...... in second complete remission.
@en
type
label
Autologous is superior to allo ...... in second complete remission.
@ast
Autologous is superior to allo ...... in second complete remission.
@en
prefLabel
Autologous is superior to allo ...... in second complete remission.
@ast
Autologous is superior to allo ...... in second complete remission.
@en
P2093
P2860
P1476
Autologous is superior to allo ...... in second complete remission.
@en
P2093
Andrew Grigg
Daniel J Weisdorf
George B Selby
Hai-Lin Wang
Jacob M Rowe
Jeffrey Szer
Jennifer L Holter Chakrabarty
Morel Rubinger
P2860
P304
P356
10.1016/J.BBMT.2014.03.025
P577
2014-03-30T00:00:00Z